Advanced Specialty Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.23 M
as on 15-11-2024
- Company Age 17 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.91 M
as on 15-11-2024
- Revenue -26.99%
(FY 2023)
- Profit -150.74%
(FY 2023)
- Ebitda -135.97%
(FY 2023)
- Net Worth -11.51%
(FY 2023)
- Total Assets -5.66%
(FY 2023)
About Advanced Specialty Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.23 M.
The company has closed loans amounting to ₹4.91 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jagdish Marthak and Vallari Marthak serve as directors at the Company.
- CIN/LLPIN
U85110MH2007PTC177002
- Company No.
177002
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Advanced Specialty Hospitals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Marthak  | Director | 04-Jun-2024 | Current |
| Vallari Marthak | Director | 04-Jun-2024 | Current |
Financial Performance of Advanced Specialty Hospitals.
Advanced Specialty Hospitals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.99% decrease. The company also saw a substantial fall in profitability, with a 150.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Specialty Hospitals?
In 2023, Advanced Specialty Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Apr 2019 | ₹1.60 M | Satisfied |
Others Creation Date: 05 Sep 2018 | ₹0.94 M | Satisfied |
Others Creation Date: 07 Oct 2016 | ₹1.02 M | Satisfied |
How Many Employees Work at Advanced Specialty Hospitals?
Advanced Specialty Hospitals has a workforce of 61 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Specialty Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Specialty Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
